URM1 and breast cancer: Collectively, our study unveils a novel interaction of URM-1, a ubiquitin-related modifier, with Cx43, a widely recognized gap junction protein with a tumor suppressor role in breast cancer, and demonstrates that the loss of URM-1 promotes EMT, while the upregulation of URM-1 drives EMT reversal in breast cancer.